- Retraction Note
- Open Access
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
https://doi.org/10.1186/1756-0500-7-868
© Ngemu et al.; licensee BioMed Central Ltd. 2014
- Received: 20 November 2014
- Accepted: 20 November 2014
- Published: 25 November 2014
The original article was published in BMC Research Notes 2014 7:52
Retraction
This article [1] has been retracted by the editors of BMC Research Notes because, contrary to the statement in the manuscript, Moi University Institutional Research and Ethics Committee (IREC) has confirmed that ethics approval was not obtained to conduct this study. In addition, the authors did not have permission to use data from the DREAM program.
Notes
Authors’ Affiliations
References
- Ngemu EK, Khayeka–Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E: Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes. 2014, 7: 52-10.1186/1756-0500-7-52.PubMedPubMed CentralView ArticleGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
